Enright William
Insider CIK 1705564 · NASDAQ:ALT See Remarks, Director · BRNS Chief Executive Officer, Director · BFRG,BFRGW Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 600,000 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 176,130 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 359,605 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 440,000 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 443,981 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer | 2026-09-09 | 2026-09-09 | 514,923 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer | 2026-09-09 | 2026-09-09 | 728,454 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 600,000 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 443,981 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 440,000 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 359,605 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer deriv | 2026-09-09 | 2026-09-09 | 176,130 | — | $0 | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer | 2026-09-09 | 2026-09-09 | 514,923 | — | — | 0 | SEC↗ |
| BRNS Barinthus Biotherapeutics | D To issuer | 2026-09-09 | 2026-09-09 | 728,454 | — | — | 0 | SEC↗ |
| BFRG BullFrog AI Holdings, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BFRG BullFrog AI Holdings, Inc. | A Award deriv | 2025-09-25 | 2025-09-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BFRG BullFrog AI Holdings, Inc. | A Award | 2025-08-22 | 2025-08-26 | 2,813 | — | $0 | 13,523 | SEC↗ |
| BFRG BullFrog AI Holdings, Inc. | A Award | 2025-08-22 | 2025-08-26 | 5,710 | — | $0 | 10,710 | SEC↗ |
| BRNS Barinthus Biotherapeutics | A Award deriv | 2025-02-03 | 2025-02-05 | 600,000 | — | $0 | 600,000 | SEC↗ |
| BRNS Barinthus Biotherapeutics | A Award deriv | 2024-01-02 | 2024-01-04 | 443,981 | — | $0 | 443,981 | SEC↗ |
| BFRG,BFRGW BullFrog AI Holdings, Inc. | P Buy | 2023-06-14 | 2023-06-15 | 5,000 | $4.05 | $20.3K | 5,000 | SEC↗ |
| BFRG,BFRGW BullFrog AI Holdings, Inc. | A Award deriv | 2023-04-16 | 2023-05-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VACC Vaccitech plc | S Sale | 2023-03-27 | 2023-03-29 | 15,000 | $2.42 | $36.3K | 728,454 | SEC↗ |
| VACC Vaccitech plc | A Award deriv | 2023-01-03 | 2023-02-23 | 440,000 | — | $0 | 440,000 | SEC↗ |
| VACC Vaccitech plc | A Award deriv | 2022-01-03 | 2022-02-11 | 359,605 | — | $0 | 359,605 | SEC↗ |
| VACC Vaccitech plc | A Award | 2021-05-04 | 2021-05-07 | 514,923 | — | $0 | 1,258,377 | SEC↗ |
| VACC Vaccitech plc | A Award deriv | 2021-04-29 | 2021-05-04 | 176,130 | — | $0 | 176,130 | SEC↗ |
| VACC Vaccitech plc | A Award | 2021-04-29 | 2021-05-04 | 455,775 | — | $0 | 1,199,229 | SEC↗ |
| ALT Altimmune, Inc. | P Buy | 2018-05-25 | 2018-05-29 | 1,300 | $0.51 | $663 | 365,839 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2018-05-21 | 2018-05-23 | 103,158 | — | $0 | 103,158 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 183,347 | — | $0 | 0 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 183,347 | $0.08 | $14.7K | 364,511 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2017-09-22 | 2017-09-26 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2017-08-16 | 2017-08-18 | 71,644 | — | $0 | 0 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2017-08-16 | 2017-08-18 | 91,733 | — | $0 | 0 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2017-08-16 | 2017-08-18 | 91,733 | $0.08 | $7.3K | 181,164 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2017-08-16 | 2017-08-18 | 71,644 | $0.08 | $5.7K | 89,431 | SEC↗ |
| NASDAQ:ALT Altimmune, Inc. | A Award deriv | 2017-05-04 | 2017-05-08 | 125,887 | — | $0 | 125,887 | SEC↗ |
| NASDAQ:ALT Altimmune, Inc. | A Award deriv | 2017-05-04 | 2017-05-08 | 91,733 | — | $0 | 91,733 | SEC↗ |
| NASDAQ:ALT Altimmune, Inc. | A Award deriv | 2017-05-04 | 2017-05-08 | 183,347 | — | $0 | 183,347 | SEC↗ |
| NASDAQ:ALT Altimmune, Inc. | A Award deriv | 2017-05-04 | 2017-05-08 | 71,644 | — | $0 | 71,644 | SEC↗ |
| NASDAQ:ALT Altimmune, Inc. | A Award deriv | 2017-05-04 | 2017-05-08 | 99,927 | — | $0 | 99,927 | SEC↗ |
| NASDAQ:ALT Altimmune, Inc. | A Award | 2017-05-04 | 2017-05-08 | 17,787 | — | $0 | 17,787 | SEC↗ |